Frontlight ResearchEarly access
Trial site
Alicante
- 3running trials
- 7closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Familial hypercholesterolaemia2 trials
- Multiple sclerosis2 trials
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Myeloproliferative neoplasms1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals10 trials
Running trials
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026